FI915819A0 - Hiv- proteas-inhibitorer. - Google Patents

Hiv- proteas-inhibitorer.

Info

Publication number: FI915819A0
Authority: FI; Finland
Prior art keywords: hiv; proteas; inhibitor; aids; inhibitors
Prior art date: 1990-12-11

Application number

FI915819A

Other languages

English (en)

Other versions

FI915819L (fi

FI108113B (fi

Inventor

Tsutomu C O Nippon Mini Mimoto

Naoko C O Nippon Minin Hattori

Makoto C O Nippon Min Shintani

Yuuichi C O Nippon Mini Nagano

Yoshiaki Kiso

Original Assignee

Nippon Mining Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-11

Filing date

1991-12-11

Publication date

1991-12-11

1991-12-11 Application filed by Nippon Mining Co filed Critical Nippon Mining Co

1991-12-11 Publication of FI915819A0 publication Critical patent/FI915819A0/fi

1992-06-12 Publication of FI915819L publication Critical patent/FI915819L/fi

2001-11-30 Application granted granted Critical

2001-11-30 Publication of FI108113B publication Critical patent/FI108113B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Virology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Crystallography & Structural Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pyrrole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Quinoline Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Thiazole And Isothizaole Compounds (AREA)

FI915819A 1990-12-11 1991-12-11 Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi FI108113B (fi)

Applications Claiming Priority (10)

Application Number	Priority Date	Filing Date	Title
JP40967390		1990-12-11
JP40967390		1990-12-11
JP2575591		1991-01-25
JP2575591		1991-01-25
JP8997691		1991-03-28
JP8997691		1991-03-28
JP16917491		1991-06-14
JP16917491		1991-06-14
JP30404391		1991-10-23
JP30404391		1991-10-23

Publications (3)

Publication Number	Publication Date
FI915819A0 true FI915819A0 (fi)	1991-12-11
FI915819L FI915819L (fi)	1992-06-12
FI108113B FI108113B (fi)	2001-11-30

Family

ID=27520768

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI915819A FI108113B (fi)	1990-12-11	1991-12-11	Menetelmä HIV-proteaasi-inhibiittoreiden valmistamiseksi

Country Status (10)

Country	Link
EP (1)	EP0490667B1 (fi)
JP (1)	JP2700511B2 (fi)
AT (1)	ATE181080T1 (fi)
AU (1)	AU653972B2 (fi)
CA (1)	CA2056911C (fi)
DE (1)	DE69131317T2 (fi)
DK (1)	DK0490667T3 (fi)
ES (1)	ES2134764T3 (fi)
FI (1)	FI108113B (fi)
GR (1)	GR3031004T3 (fi)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5976541A (en) *	1988-01-26	1999-11-02	The United States Of America As Represented By The Department Of Health And Human Services	Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
JP2500034B2 (ja) *	1991-02-08	1996-05-29	三共株式会社	β−アミノ−α−ヒドロキシカルボン酸誘導体
US5679688A (en) *	1992-03-11	1997-10-21	Narhex Limited	Quinaldoyl-amine derivatives of oxo-and hydroxy-substituted hydrocarbons
ATE253050T1 (de)	1992-03-11	2003-11-15	Narhex Ltd	Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
US6071895A (en) *	1992-03-11	2000-06-06	Narhex Limited	Polar-substituted hydrocarbons
US5888992A (en) *	1992-03-11	1999-03-30	Narhex Limited	Polar substituted hydrocarbons
US5644028A (en) *	1992-05-13	1997-07-01	Japan Energy Corporation	Process for producing peptide derivatives and salts therefor
US5559256A (en) *	1992-07-20	1996-09-24	E. R. Squibb & Sons, Inc.	Aminediol protease inhibitors
IL106600A (en) *	1992-08-07	1997-09-30	Sankyo Co	Peptides, pharmaceutical compositions containing the same and processes for the preparation thereof
US5846993A (en) *	1992-12-22	1998-12-08	Agouron Pharmaceuticals, Inc.	HIV protease inhibitors
US5484926A (en) *	1993-10-07	1996-01-16	Agouron Pharmaceuticals, Inc.	HIV protease inhibitors
IL110898A0 (en) *	1993-09-10	1994-11-28	Narhex Australia Pty Ltd	Polar-substituted hydrocarbons
IL110752A (en) *	1993-09-13	2000-07-26	Abbott Lab	Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
US5559158A (en) *	1993-10-01	1996-09-24	Abbott Laboratories	Pharmaceutical composition
US5527829A (en) *	1994-05-23	1996-06-18	Agouron Pharmaceuticals, Inc.	HIV protease inhibitors
DE69524527D1 (de) *	1994-10-14	2002-01-24	Japan Energy Corp	AIDS-hemmende Arzneizubereitung und Verfahren
AU4188096A (en) *	1994-12-14	1996-07-03	Sankyo Company Limited	Ahpba-containing tripeptide derivative
US6008228A (en) *	1995-06-06	1999-12-28	Hoffman-La Roche Inc.	Pharmaceutical compositions containing proteinase inhibitors
CA2179935C (en) *	1995-06-30	2010-09-07	Ryohei Kato	Novel dipeptide compound or pharmaceutically acceptable salt thereof and medical use thereof
US6222043B1 (en)	1995-06-30	2001-04-24	Japan Energy Corporation	Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
US5914332A (en)	1995-12-13	1999-06-22	Abbott Laboratories	Retroviral protease inhibiting compounds
US5962725A (en)	1996-09-05	1999-10-05	Agouron Pharmaceuticals, Inc.	Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir
US5925759A (en)	1996-09-05	1999-07-20	Agouron Pharmaceuticals, Inc.	Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors
US5705647A (en) *	1996-09-05	1998-01-06	Agouron Pharmaceuticals, Inc.	Intermediates for making HIV-protease inhibitors
US6174905B1 (en)	1996-09-30	2001-01-16	Mitsui Chemicals, Inc.	Cell differentiation inducer
US6794392B1 (en)	1996-09-30	2004-09-21	Schering Aktiengesellschaft	Cell differentiation inducer
US6232333B1 (en)	1996-11-21	2001-05-15	Abbott Laboratories	Pharmaceutical composition
WO1998029118A1 (fr) *	1996-12-27	1998-07-09	Japan Energy Corporation	Nouveaux composes de tripeptides et medicaments anti-sida
US6001851A (en) *	1997-03-13	1999-12-14	Agouron Pharmaceuticals, Inc.	HIV protease inhibitors
US6084107A (en) *	1997-09-05	2000-07-04	Agouron Pharmaceuticals, Inc.	Intermediates for making HIV-protease inhibitors
CZ304118B6 (cs)	2000-01-19	2013-11-06	Abbott Laboratories	Farmaceutická kompozice
SE0000382D0 (sv)	2000-02-07	2000-02-07	Astrazeneca Ab	New process
HN2002000136A (es) *	2001-06-11	2003-07-31	Basf Ag	Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
US7094909B2 (en)	2001-06-11	2006-08-22	Agouron Pharmaceuticals, Inc.	HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
US7169932B2 (en)	2001-06-11	2007-01-30	Pfizer Inc.	HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
AU2002359721A1 (en)	2001-12-19	2003-07-09	Bristol-Myers Squibb Company	Pichia pastoris formate dehydrogenase and uses therefor
EP1604656A1 (en)	2004-06-09	2005-12-14	Schwarz Pharma Ag	Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS)
WO2007083620A1 (ja)	2006-01-20	2007-07-26	Kaneka Corporation	β－アミノ－α－ヒドロキシ酸アミド誘導体の製造法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4656269A (en) *	1986-04-15	1987-04-07	Kissei Pharmaceutical Co., Ltd.	Histidine derivatives
EP0248562B1 (en) *	1986-06-05	1995-10-25	Zeneca Inc.	Difluoro peptide compounds
JPS6322081A (ja) *	1986-07-11	1988-01-29	Kissei Pharmaceut Co Ltd	新規なアミノ酸誘導体

1991
- 1991-12-04 CA CA002056911A patent/CA2056911C/en not_active Expired - Fee Related
- 1991-12-05 JP JP3348705A patent/JP2700511B2/ja not_active Expired - Fee Related
- 1991-12-06 AU AU88900/91A patent/AU653972B2/en not_active Ceased
- 1991-12-11 DK DK91311549T patent/DK0490667T3/da active
- 1991-12-11 AT AT91311549T patent/ATE181080T1/de not_active IP Right Cessation
- 1991-12-11 ES ES91311549T patent/ES2134764T3/es not_active Expired - Lifetime
- 1991-12-11 DE DE69131317T patent/DE69131317T2/de not_active Expired - Fee Related
- 1991-12-11 FI FI915819A patent/FI108113B/fi active
- 1991-12-11 EP EP91311549A patent/EP0490667B1/en not_active Expired - Lifetime
1999
- 1999-08-18 GR GR990402082T patent/GR3031004T3/el unknown

Also Published As

Publication number	Publication date
FI915819L (fi)	1992-06-12
DE69131317D1 (de)	1999-07-15
CA2056911A1 (en)	1992-06-12
ATE181080T1 (de)	1999-06-15
CA2056911C (en)	1998-09-22
EP0490667A2 (en)	1992-06-17
JP2700511B2 (ja)	1998-01-21
DE69131317T2 (de)	2000-01-13
ES2134764T3 (es)	1999-10-16
EP0490667B1 (en)	1999-06-09
DK0490667T3 (da)	1999-12-13
AU8890091A (en)	1992-06-18
JPH05170722A (ja)	1993-07-09
FI108113B (fi)	2001-11-30
EP0490667A3 (en)	1993-05-05
GR3031004T3 (en)	1999-12-31
AU653972B2 (en)	1994-10-20

Publication	Publication Date	Title
FI915819A0 (fi)	1991-12-11	Hiv- proteas-inhibitorer.
DE122007000045I2 (de)	2011-07-21	Darunavir oder pharmazeutisch vertragliche Salze, Hydroxyethylaminosulfonamide verwendbar als InhibiEster oder Prodrugs davon. toren retroviraler Proteasen.
NO950297D0 (no)	1995-01-26	Prolinamidderivater
DK0674513T3 (da)	1997-03-17	Retroviral protease-inhiberende forbindelser
CA2075173A1 (en)	1993-02-03	Compounds and methods for inhibition of hiv and related viruses
HU9601348D0 (en)	1996-07-29	5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents
DK0604183T3 (da)	1997-05-26	HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
MD960172A (en)	1999-01-31	5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents
DE69419954D1 (de)	1999-09-16	Arzneimittel zur Behandlung von Hauterkrankungen
DE69120396D1 (de)	1996-07-25	Neue verwendung von linomide (r)
DE69619088D1 (de)	2002-03-21	Quinoxalin-Derivate zur Behandlung von Tinnitus
DE3782229D1 (de)	1992-11-19	Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date	Code	Title	Description
1994-03-01	HC	Name/ company changed in application	Owner name: JAPAN ENERGY CORPORATION